Coca-Cola Stock Has Momentum, PepsiCo May Be the Better Buy

Coca-Cola (KO) is outperforming PepsiCo (PEP) in 2025, with KO stock up 14.5% versus PEP's 13.5% decline, driven by KO's strong earnings despite slightly lower revenue. KO's valuation, trading at approximately 28x earnings, is above its historical average and the sector, while PEP, impacted by GLP-1 drugs and inflation affecting its snack division, trades at a discount near five-year lows; however, analysts currently favor other stocks over PEP.

Analysis

In 2025, The Coca-Cola Company (KO) has demonstrated notable market outperformance, with its stock appreciating 14.5%, significantly exceeding the iShares U.S. Consumer Staples ETF's (IYK) 8% gain. This performance, which more than doubles the sector average when including KO's 2.87% dividend yield, is attributed to its earnings stability despite a slight year-over-year revenue decline, underscoring its significant pricing power. However, KO's valuation has become a point of concern, trading at approximately 28 times current earnings and 24 times forward earnings, metrics that are above both the soft drink sector average of 20.4x and KO's own historical levels, even as analysts maintain a consensus price target of $75.08 for KO stock. Conversely, PepsiCo (PEP) has faced considerable headwinds, with its stock declining 13.5% in 2025 and trading near 52-week lows, reflecting a more than 24% drop over the last 12 months. PEP's challenges stem from its snack food division's sensitivity to GLP-1 drugs and heightened food inflation, alongside a concerning 2024 financial metric where its free cash flow of $5.28 per share did not fully cover its $5.42 per share dividend, necessitating use of cash reserves. Despite these issues and a general "Hold" rating from analysts, with some reports indicating top analysts favor other stocks, PEP trades at a discounted 18x earnings, potentially appearing oversold near five-year lows, and offers a higher dividend yield of 4.33%. Both beverage giants, recognized as Dividend Kings, are navigating diversification strategies amidst scrutiny from the Secretary of Health & Human Services and the evolving impact of GLP-1 drugs on consumer preferences.

Key Decisions for Investors

• For Coca-Cola (KO), investors should acknowledge its strong 14.5% year-to-date performance and earnings resilience, but scrutinize its elevated valuation at approximately 28x earnings against its historical and sector averages before initiating or significantly adding to positions.
• PepsiCo (PEP) presents a potential value consideration, trading near five-year lows at 18x earnings with a 4.33% dividend yield, however, investors must carefully monitor its free cash flow generation, which in 2024 did not cover its dividend, and the ongoing impact of GLP-1 drugs and food inflation on its diversified portfolio.
• Investors should assess their risk tolerance for KO's premium valuation versus PEP's turnaround potential, considering both face headwinds from health trends impacting soft drinks and that analysts, while generally holding PEP, may currently see more compelling opportunities elsewhere as highlighted by MarketBeat.